Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPI-1005 in Severe COVID-19
NCT04483973Phase 2Completed
- Sponsor
- Sound Pharmaceuticals
- Start
- Aug 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ebselen in coronavirus disease 2019 (COVID-19), sponsored by Sound Pharmaceuticals. Started Aug 2021; status: completed.
02
Drugs
ebselen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04483973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04483973.